Tag: UTRF

UT Research Foundation Honors Pioneers of Progress at 2024 Innovation Awards

Written by Lee Ferguson

|
Research

UT Health Science Center researchers across the state were celebrated for their pioneering discoveries and entrepreneurial excellence at the 2024 University of Tennessee Research Foundation (UTRF) Innovation Awards. The ceremonies, held November 25 in Knoxville and December 4 in Memphis, honored the brilliant and dedicated faculty whose research-to-commercialization successes are driving real-world impact to treat… Read More

OT Chair Designs Pillow to Aid Infant Development

Written by Peggy Reisser

|
Clinical CareEducation

As a pediatric occupational therapist, Anne Zachry, PhD, OTR/L, has been a strong advocate of the importance of tummy time for the development of neck and shoulder muscles and motor skills in infants.   The chair of the Department of Occupational Therapy at UT Health Science Center and the author of two books on infant development,… Read More

Collaborative Research Leads to Creative Solution

Written by Jackie Denton

|
Clinical CareResearch

Can a candy be good for your teeth? It can be, with the right ingredients. Researchers from the College of Dentistry and the College of Pharmacy at the University of Tennessee Health Science Center have worked together to develop lollipop that is changing the way erosion of tooth enamel is treated. Searching for Options The… Read More

Scientists at UTHSC and ORNL Collaborate to Develop Potential New Treatment for Advanced Prostate Cancer

Written by Peggy Reisser

|
Research

Nearly five years after beginning their research, investigators from the University of Tennessee Health Science Center, with collaboration from scientists at Oak Ridge National Laboratory (ORNL), have found what they believe will be a next generation treatment option for advanced prostate cancer. Clinical Cancer Research, a high-impact journal in the cancer field, published a paper on… Read More

GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop SARD Drug Candidate to Treat Castration-Resistant Prostate Cancer

Written by Communications and Marketing

|
Research

GTx, Inc. today announced that it has entered into an exclusive worldwide license agreement with the University of Tennessee Research Foundation (UTRF) to develop its proprietary selective androgen receptor degrader (SARD) technology which potentially can degrade and inhibit all forms of androgen receptor (AR), including those resistant to current therapies, to inhibit tumor growth in… Read More